Phase III oncology clinical trial starts growth rate
Global, 2024–2025 to 2025
4%
2025
Phase III oncology clinical trial starts growth rate: Global, 2024–2025 to 2025
Phase III oncology clinical trial starts growth rate: Global, 2024–2025 to 2025. 2 observations from 2024–2025 to 2025, ranging from 4% to 4%. Latest value 4% (2025).
%
0
1
2
3
4
2024
2025
4%
4%
Phase III oncology clinical trial starts growth rate: Global, 2024–2025 to 2025
Phase III oncology clinical trial starts growth rate: Global, 2024–2025 to 2025. 2 observations from 2024–2025 to 2025, ranging from 4% to 4%. Latest value 4% (2025).
%
0
1
2
3
4
2024
2025
4%
4%
Phase III oncology clinical trial starts growth rate: Global, 2024–2025 to 2025
Phase III oncology clinical trial starts growth rate: Global, 2024–2025 to 2025. 2 observations from 2024–2025 to 2025, ranging from 4% to 4%. Latest value 4% (2025).
%
0
1
2
3
4
2024
2025
4%
4%
View the underlying data
Phase III oncology clinical trial starts growth rate: Global, 2024–2025 to 2025
Period
Type
Value
2024–2025
Actual
4%
2025
Actual
4%
Chart:
StatOrigin
· Source: IQVIA ·
statorigin.org
CC BY 4.0